Second-quarter earnings season is in full swing, and the results have been largely resilient so far. So why are stocks ...

Walt Disney posted better-than-expected results for April through June and raised its full-year earnings guidance on ...

Earnings jumped to $1.03 a share, up from $0.60 a year ago, as Emerson ( NYSE: EMR) improved its pretax margin by 570 basis ...

Q2 2025 Management View Dave Cramer, President and CEO, reported sequential improvement in occupancy and contract rates, but ...

Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.

DAVE INC (DAVE) delivered earnings and revenue surprises of +65.26% and +16.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Q3 2025 Management View Stephen D. Westhoven, President and CEO, indicated, "Fiscal 2025 continues to be an excellent year ...

This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Arbutus (ABUS) delivered earnings and revenue surprises of +150.00% and +496.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Earnings per share is one of the best metrics of a company’s financial health. In this guide, Benzinga discusses the ins and outs of earnings per share (EPS).

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...